Bilberry Ginkgo Eyebright Complex Plus Lutein
On sale on the US market (according to the DSLD)
Solgar, food supplement from the US market
Bilberry Ginkgo Eyebright Complex Plus Lutein (Solgar), a food supplement au code-barres 033984003163, is described by its US market label. If sold in France, it would be subject to 2 points of French or European regulation, detailed below. Doses of vitamine A are not compared: their US units depend on the form. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine C: up to 300 mg a day according to the label (at most 1 serving a day), above the maximum dose of 180 mg set in France for a food supplement (2006 Order, not revised since November 2006).
Source: French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), arrêté du 9 mai 2006, annexe III.
- Dose déclarée au-delà d'une limite
Vitamine E: up to 67 mg a day according to the label (at most 1 serving a day), above the maximum dose of 30 mg set in France for a food supplement (2006 Order, not revised since November 2006).
Source: French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), arrêté du 9 mai 2006, annexe III.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Solgar
- Barcode
- 033984003163
- Form
- Capsule
- One serving
- 2 vegetarian capsules
- Servings
- up to 1 serving per day
- Other ingredients (in English, as written)
- Vegetable Cellulose, Silica, Vegetable Magnesium Stearate, natural Caramel color, Maltodextrin
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Vitamin A | Vitamin | 1,500 µg |
| Beta-Carotene | Vitamin | 1,200 µg |
| Vitamin A Palmitate | Vitamin | 300 µg |
| Vitamin C | Vitamin | 300 mg |
| Vitamin E | Vitamin | 67 mg |
| Zinc | Mineral | 10 mg |
| Selenium | Mineral | 25 µg |
| Lutein | Other substance | 10 mg |
| Eyebright extract | Plant | 25 mg |
| Bilberry extract | Plant | 20 mg |
| Ginkgo biloba extract | Plant | 10 mg |
| NAC | Other substance | 100 mg |
| Taurine | Other substance | 100 mg |
| Mixed Carotenoids | Other substance | 46 µg |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Bilberry Ginkgo Eyebright Complex Plus Lutein
Entered into DSLD on 22 September 2016. Withdrawn from the US market on 18 November 2019 (according to the DSLD).- Active ingredient added : Alpha-Carotene (quantity not stated)
- Active ingredient added : Anthocyanosides (5 mg)
- Active ingredient added : Cryptoxanthin (quantity not stated)
- Active ingredient added : Ginkgoflavoglycosides (2.4 mg)
- Active ingredient added : Lutein (quantity not stated)
- Active ingredient added : Zeaxanthin (quantity not stated)
- Active ingredient removed : Vitamin A Palmitate (300 mcg)
- Different unit, without conversion : Beta-Carotene: quantity not stated in this version; 1,200 mcg on the displayed label
- Different unit, without conversion : Vitamin A: 5,000 IU in this version; 1,500 mcg on the displayed label
- Different unit, without conversion : Vitamin E: 100 IU in this version; 67 mg on the displayed label
Official label: Bilberry Ginkgo Eyebright Complex Plus Lutein
Entered into DSLD on 24 April 2015. Withdrawn from the US market on 9 September 2016 (according to the DSLD).- Active ingredient added : Alpha {Carotene} (quantity not stated)
- Active ingredient added : Anthocyanosides (5 mg)
- Active ingredient added : Cryptoxanthin (quantity not stated)
- Active ingredient added : Ginkgo Flavone Glycosides (2.4 mg)
- Active ingredient added : Lutein (quantity not stated)
- Active ingredient added : Zeaxanthin (quantity not stated)
- Same quantity, different name: Ginkgo biloba leaf extract in this version; Ginkgo biloba extract on the displayed label (10 mg)
- Different unit, without conversion : Beta-Carotene: 4,000 IU ; quantity not stated in this version; 1,200 mcg on the displayed label
- Different unit, without conversion : Vitamin A: 5,000 IU in this version; 1,500 mcg on the displayed label
- Different unit, without conversion : Vitamin A Palmitate: 1,000 IU in this version; 300 mcg on the displayed label
- Different unit, without conversion : Vitamin E: 100 IU in this version; 67 mg on the displayed label
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- NAC
Read the warning, when it applies and the studies cited
N-ACETYL-L-CYSTEINE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney stones (Fauci et al. 1998; Mårtensson et al. 1990).
Sources cited by Health Canada (2)
- Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DI, Hauser SL and Longo DL, editors. Harrison's Principles of Internal Medicine, 14th edition. Toronto (ON): McGraw-Hill Health Professions Division; 1998.
- Mårtensson J, Denneberg T, Lindell Å, Textorius O. Sulfur amino acid metabolism in cystinuria : A biochemical and clinical study of patients. Kidney International 1990;37:143-149. PubMed
Contraindications
Do not use if you are taking antibiotics or nitroglycerin (Repchinsky 2008; Cederlund and Märdh 1993; Parry and Neu 1977; Ardissino et al. 1997).
Sources cited by Health Canada (4)
- Ardissino D, Merlini PA, Savonitto S, Demicheli G, Zanini P, Bertocchi F, Falcone C, Ghio S, Marinoni G, Montemartini C, Mussini A. Effect of transdermal nitroglycerin or N- acetylcysteine, or both, in the long-term treatment of unstable angina pectoris. Journal of the American College of Cardiology 1997;29(5):941-947. PubMed Randomised trial
- Cederlund H, Märdh PA. Antibacterial activities of non-antibiotic drugs. Journal of Antimicrobial Chemotherapy 1993;32:355-365. PubMed Review article
- Parry MF, Neu HC. Effect of N-acetylcysteine on antibiotic activity and bacterial growth in vitro. Journal of Clinical Microbiology 1977;5(1);58-61.
- Repchinsky C, editor. Compendium of Pharmaceuticals and Specialties. The Canadian Drug Reference for Health Professionals. Ottawa (ON): Canadian Pharmacists Association; 2008.
- Taurine
Read the warning, when it applies and the studies cited
TAURINE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Lopez Ramon et al. 2007; Seghieri et al. 2007).
Sources cited by Health Canada (2)
- López Ramón Y Cajal C, Ocampo Martínez R, Couceiro Naveira E, Martínez M. Amino acids in amniotic fluid in the 15th-16th weeks of gestation and preterm labor. The Journal of Maternal-Fetal & Neonatal Medicine: the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 2007;20(3):225-231.
- Seghieri G, Tesi F, Bianchi L, Loizzo A, Saccomanni G, Ghirlanda G, Anichini R, Franconi F. Taurine in women with a history of gestational diabetes. Diabetes Research and Clinical Practice 2007;76(2):187-192. PubMed
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Solgar
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Bilberry Ginkgo Eyebright Complex Plus Lutein (Solgar): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/33984003163-bilberry-ginkgo-eyebright-complex-plus-lutein-solgar, updated 23 April 2020.